Trump Touts Economic Boom, Semiconductor Resurgence, and Strong South Korea Ties Amidst Geopolitical Tensions
Key Takeaways President Trump projects $21-22 trillion in new investments into the U.S. economy by the end of his second […]
Breaking News
Global Markets Eye Rupee Stability, Bond Yields, Trump’s Trade Clarification, and Goldman Sachs’ BOE Rate Shift
Key Takeaways The Indian Rupee opened stronger against the U.S. dollar at 88.21, appreciating from its previous close of 88.26.
US-Japan Alliance Strengthens Amid Regional Tensions; Japan Exchange Group Reports Strong Q2 Earnings
Key Takeaways Japan Exchange Group ((/stock/8697)) reported robust Q2 2025 earnings, with net income rising 5.9% year-over-year to ¥17.52 billion
Global Diplomacy and Trade Shape Markets Amid Key US-Asia Engagements
Key Takeaways The United States and Thailand have issued a joint statement affirming that exchange rates will not be targeted
Global Markets React to Geopolitical Developments and Central Bank Stance
Key Takeaways Japan's Chief Cabinet Secretary Kihara emphasized the Bank of Japan's (BOJ) role in monetary policy to achieve inflation
Global Markets React to Trump’s Diplomatic Outlook and Major Corporate Shifts
Key Takeaways Global markets show mixed signals: South Korea's KOSPI index surged 1.4% to a record 4,065.36 points, while options
Global Markets React to Nvidia’s AI Dominance, Fed Rate Cut Expectations, and Surging Auto Repossessions
Key Takeaways Nvidia (NVDA) announced a staggering $500 billion in AI chip bookings and plans to build seven new AI
Global Markets Navigate Trade Hopes, Energy Debt, and Central Bank Cuts
Key Takeaways UK lawmakers have urged the government to utilize approximately £4.15 billion in "windfall profits" from energy grid companies
Global Markets Navigate Geopolitical Tensions, AI Boom, and Shifting Trade Dynamics
Key Takeaways AI-driven tech euphoria is significantly impacting global markets, boosting chip demand and M&A activity, while simultaneously reducing safe-haven
Novartis Shares Dip as Generics Dent Blockbuster Heart Drug Entresto
Key Takeaways Novartis (NOVN) shares fell over 3% in early trading after its top-selling heart drug, Entresto, saw sales growth